STAT+: Pharmalittle: Lawmakers ramp up probe of FDA approval of Biogen drug; EU to return J&J Covid-19 shots to Africa
And so, another working week will soon draw to a close. Not a moment too…
Category: Pharma
The Purdue bankruptcy plan was approved. Will it get derailed by appeals?
A bankruptcy court has approved a settlement to funnel billions of dollars to pay for…
STAT+: Older job seekers claim that Lilly favors millennials when it comes to hiring sales reps
In order to win the attention of physicians, Eli Lilly (LLY) has deliberately sought to…
Purdue bankruptcy settlement leaves families angry, conflicted
Among the families who lost children and other loved ones in the nation’s opioid crisis,…
STAT+: Pharmalittle: Purdue bankruptcy plan is approved but appeals expected; FDA warns about safety risks with arthritis drugs
Top of the morning to you. And a fine one it is. Lots of sunshine…
Judge approves Purdue’s controversial bankruptcy plan, paving the way for immunity for Sacklers
After two years of contentious bargaining, a U.S. bankruptcy court judge on Wednesday approved a…
STAT+: Pharmalittle: Two key FDA officials leaving amid Covid-19 booster debate; is Biden really ‘following the science’?
Hello, everyone, and welcome to the middle of the week. You made it this far,…
STAT+: Pharmalittle: BIO wrestles with inner turmoil; J&J HIV vaccine failed to prevent infection
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT+: ‘A step in the right direction for national security’: An antibiotic plant reopens in Tennessee to make penicillin
Amid a push to bolster antibiotic manufacturing in the U.S., a facility that closed last…
STAT+: Pharmalittle: Contaminants found in Moderna Covid-19 vaccine in Japan; demand rises for ivermectin to treat the coronavirus
Good morning, everyone, and nice to see you again. We have returned from a week-long…
Inside Pfizer’s labs, ‘variant hunters’ race to stay ahead of the pandemic’s next twist
PEARL RIVER, N.Y. — Delta was tearing its way through India and, as the death…
STAT+: Pharmalittle: Judge delays ruling on Purdue opioid settlement; Biomarin dwarfism drug cleared in Europe
Good day, everyone! Nick Florko here filling in for the great Ed Silverman. I’m here…
STAT+: Pharmalittle: Judge plans to rule on Purdue settlement Friday; Biden administration considering Covid boosters after six months
Good morning, fellow humans. Erin Brodwin here, filling in for Ed Silverman. My unofficial mascot,…
STAT+: Pharmalittle: Second J&J vaccine dose boosts antibodies against Covid; age lowered for diabetes screening
Good morning! Katie Palmer here, tagging in for Ed Silverman as he embraces the final…
.jpg)
Pharmalittle: New wave of employer Covid-vaccine mandates expected; drug makers and FDA agree on new programs for rare-disease drugs
Good morning! This is Lev Facher, subbing today for Ed Silverman. I’d be remiss not…
STAT+: FDA, drug makers propose new pilots aimed at speeding rare disease drugs, as part of user fee update
WASHINGTON — The Food and Drug Administration and the drug industry have jointly agreed to…
STAT+: Pharmalittle: Pfizer to buy Trillium in $2.3 billion deal; Israel data find additional vaccine dose lowers Covid risk
Good morning everyone, hope you’re savoring the fresh start that comes with the beginning of…
.jpg)
STAT+: Pharmalittle: Biden reportedly rules out Woodcock as FDA commish; J&J’s Gorsky is stepping aside as CEO
And so, another working week will soon draw to a close. Not a moment too…
STAT+: After company protest, FDA agrees to review controversial drug to prevent premature birth
In an unexpected turn of events, the Food and Drug Administration will hold a hearing…
STAT+: Medical journal editorial writers have financial conflicts of interest, too
In the latest look at conflicts of interest in science, a new analysis found 15%…
STAT+: Pharmalittle: FDA advisory panel members want negative votes to matter more; Illumina closes Grail deal despite regulatory hurdles
Good morning, folks. How are you today? Once again, sunny skies and a cool breeze…
‘Remember her as the badass she was’: ALS patient who died should force Biogen, others to anticipate expanded access issues
It’s been two weeks since Lisa Stockman Mauriello passed away and a lingering question, in…
STAT+: WHO urges Roche to ensure equitable access of Covid-19 treatment amid global shortage
The World Health Organization and Unitaid called on Roche (RHHBY) to ensure that existing doses…
STAT+: Pharmalittle: Sesen Bio drug trial marked by misconduct; a Sackler threatens opioid settlement if immunity not granted
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT+: David Sackler acknowledges ‘moral responsibility’ to address opioid crisis, but refuses to pay settlement without immunity
Amid a contentious bankruptcy court trial, a member of the Sackler family that owns Purdue…
STAT+: As use of widely prescribed stimulants increases, experts see troubling parallels to opioid crisis
A new study found that the number of adults who used two widely prescribed stimulants…
STAT+: Former Medivation exec charged with insider trading after buying stock ‘within minutes’ of learning of a deal
Just days before Pfizer (PFE) announced plans to acquire Medivation six years ago, the former…
STAT+: Pharmalittle: Roche reports Actemra shortages due to Delta variant; J&J exports Covid-19 shots made in Africa to Europe
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: Pharmalittle: Merck is latest drug maker to end 340B discounts; ‘fractionation’ is promoted to stretch Covid-19 vaccines
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Pfizer says ‘trust us’ when it comes to a Covid-19 booster; FDA OKs extra dose of the mRNA shots for some people
And so, another working week will soon come to an end. Not a moment too…
STAT+: As Bluebird backpedals from Europe, small gene and cell therapy players face tough hurdles
After Bluebird Bio (BLUE) announced plans this week to end commercial operations in Europe, the…
STAT+: Pharmalittle: Biden pushes Congress to let Medicare negotiate drug prices; National Academies failed to disclose pharma-friendly committee ties
Rise and shine, another busy day is on the way. And it will be steamy…
Opinion: STAT+: To ensure equity and accuracy, clinical research must reflect the diversity of patients
In the journey from lab to label for a new and promising treatment, clinical research…
STAT+: Veterans Affairs declines to cover Biogen Alzheimer’s drug over effectiveness and safety concerns
The Department of Veterans Affairs has decided not to cover a new Alzheimer’s drug from…
STAT+: Pharmalittle: WHO to lead trial testing three drugs as Covid-19 salves; patient access to antibiotics lacking in wealthy countries
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
STAT+: ‘Things are so messed up’: Patient access to antibiotics is lacking even in the wealthiest countries
Although 18 innovative antibiotics were approved by regulators in the wealthiest nations over the past…
STAT+: Pharmalittle: Bluebird to wind down European operations over pricing; whither the FDA’s accelerated approval pathway?
Good morning, everyone, and how are you today? The sun is trying to peek through…
STAT+: After leaving patients in limbo, Pfizer agrees to sell a discontinued glaucoma drug
After months of controversy, Pfizer (PFE) has reached a deal to sell a decades-old eye…
STAT+: Pharmalittle: Still no word from Biden on a new FDA chief; CMS pulls ‘most favored nation’ rule for lowering drug prices
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
STAT+: As White House mulls FDA commissioner job, a sign of industry backing for Woodcock surfaces
Shortly after the Biden administration took office, a letter-writing campaign erupted over who should be…
STAT+: Pharmalittle: FDA expects to have Covid booster plan by early September; feds halt Novavax vaccine funding
Wakey-wakey, everyone. It’s Friday! You can sip your cup of stimulation with satisfaction this morning:…
STAT+: A federal appeals court throws into question the fate of ‘skinny labels’ — and access to generic drugs
In a decision with enormous implications for the U.S. health care system, a federal appeals…
STAT+: U.K. antitrust watchdog issues a provisional ruling that Pfizer engaged in price gouging
After being forced to reassess its original findings, a U.K. antitrust watchdog has issued a…
STAT+: Pharmalittle: HHS watchdog to review FDA approval of Alzheimer’s drug; Moderna sold $4.2 billion of its Covid-19 vaccine
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Bayer inks a $1.5 billion deal for a biotech with a proprietary drug discovery platform
In a bid to quickly broaden its drug discovery abilities, Bayer (BAYRY) has reached a…
STAT+: Federal watchdog will review the controversial FDA approval of Biogen’s Alzheimer’s drug
The federal watchdog at the Department of Health and Human Services will review the process…
STAT+: Canadian agency loses a battle in effort to force a drug maker to lower ‘excessive’ pricing
In a withering ruling, a Canadian appeals court overturned a controversial decision issued four years…
STAT+: Pharmalittle: FDA aims to fully approve Pfizer Covid-19 vaccine by Labor Day; SoftBank grabs $5 billion stake in Roche
Rise and shine, everyone, the middle of the week is already here. Congratulations on making…
STAT+: FDA to importer: keep your active pharma ingredients away from weed killer and antifreeze
What do weed killer, engine antifreeze coolant, dry wall repair products, and active pharmaceutical ingredients…
STAT+: Pharmalittle: Sanofi to pay $3.2 billion to buy Translate Bio; COVAX struggles with Covid-19 vaccine distribution
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…